Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
Raf/MEK/ERK and phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) cascades are key signalling pathways interacting with each other to regulate cell growth and tumourigenesis. We have previously shown B-Raf and Akt overexpression and/or overactivation in pituitary adenomas...
Үндсэн зохиолчид: | Dworakowska, D, Wlodek, E, Leontiou, C, Igreja, S, Cakir, M, Teng, M, Prodromou, N, Góth, M, Grozinsky-Glasberg, S, Gueorguiev, M, Kola, B, Korbonits, M, Grossman, AB |
---|---|
Формат: | Journal article |
Хэл сонгох: | English |
Хэвлэсэн: |
2009
|
Ижил төстэй зүйлс
Ижил төстэй зүйлс
-
The role of somatostatin analogues in the treatment of neuroendocrine tumours.
-н: Grozinsky-Glasberg, S, зэрэг
Хэвлэсэн: (2008) -
The pathology of pituitary adenomas from a clinical perspective.
-н: Dworakowska, D, зэрэг
Хэвлэсэн: (2011) -
Novel molecular aspects of pituitary adenomas.
-н: Hubina, E, зэрэг
Хэвлэсэн: (2005) -
Targeting Aberrant RAS/RAF/MEK/ERK Signaling for Cancer Therapy
-н: Ufuk Degirmenci, зэрэг
Хэвлэсэн: (2020-01-01) -
The pathophysiology of pituitary adenomas.
-н: Dworakowska, D, зэрэг
Хэвлэсэн: (2009)